Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2161–2180 of 17,529 recalls

April 27, 2023· Teva Pharmaceuticals USA Inc

Recalled Item: Fentanyl Buccal Tablets CII

The Issue: Labeling: Incorrect or Missing Package Insert

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 27, 2023· Teva Pharmaceuticals USA Inc

Recalled Item: Fentanyl Buccal Tablets CII

The Issue: Labeling: Incorrect or Missing Package Insert

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Levofloxacin Injection 500mg/20 mL (25 mg/mL)

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Clobetasol Propionate Cream

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Levofloxacin Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Tropicamide Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Calcitriol Injection 1 mcg/mL

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Azelastine Hydrochloride Nasal Spray

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Levocarnitine Oral Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Ciclopirox Topical Solution 8% (Nail Lacquer)

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Artificial Tears Ointment

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Lidocaine 2.5% & Prilocaine 2.5% Cream

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Megestrol Acetate Oral Suspension

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Ferrous Sulfate Iron Supplement Drops

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Artificial Tears Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Clobetasol Propionate Ointment

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Rifampin Capsules USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Ephedrine Sulfate Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund